CALCIUM AND PHOSPHOROUS NUTRITION IN HIGH RISK INFANTS
Project Number1R01HD018505-01A1
Contact PI/Project LeaderTSANG, REGINALD C
Awardee OrganizationUNIVERSITY OF CINCINNATI
Description
Abstract Text
Dramatic increases in survival of high risk neonates have occurred in the
last decade. Each year a quarter of a million low birth weight infants are
born in the U.S. Most of these infants now survive from intensive care
nurseries. Nutritional support for these high risk infants is now the
major concern of neonatologists, and mineral nutrient support is the major
nutritional concern. The purpose of the present study is to determine the
mechanisms of skeletal mineralization in infancy in relation to provision
and availability of calcium, phosphorus and vitamin D with two modes of
nutrient support commonly used in high risk neonates: parenteral nutrition
(PN) and human milk feeding. In Part I the specific purpose is to
determine the effect of high versus usual calcium and phosphorus content in
infusates on bone mineral content and on serum Ca, P and calciotropic agent
concentrations. We propose to test the hypothesis that high Ca and P
content with low doses of vit. D in parenteral nutrition solutions will
result in increased bone mineral content (BMC) in infants when compared to
those on usual Ca and P content in parenteral nutrition fluids with similar
doses of vit. D. We hypothesize that preterm infants receiving the high
parenteral nutrition regimen will have BMC that approaches BMC in utero,
and term infants receiving the high regimen will have BMC that resembles
normal infants on human milk; furthermore, high Ca and P supplementation
with low vit. D will not result in serum abnormalities of Ca and P. Fifty
infants will be studied in a prospective randomized trial. The infants
will be matched for weight and gastrointestinal abnormalities. Physical
examination and serum Ca, P, magnesium, alkaline phosphatase and bone
GLA-protein, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D,
24,25-dihydroxyvitamin D, D binding protein, parathyroid hormone, and
calcitonin will be measured. BMC by infant adapted photon absorptiometry
and x-ray studies for detection of rickets will be performed. In Part II
the purpose is to test the hypothesis that rickets and osteopenia occurs in
very low birth weight infants fed human milk even with supplementation with
vit. D and that rickets and osteopenia in such infants can be prevented by
supplementing with Ca and P. A prospective randomized trial will be
performed in 50 infants with birth weights less than 1500 gm. matched for
sex, race and weight. Clinical and laboratory investigations will be
similar to Part I. Supplemented group will be compared with unsupplemented
for rate of rickets, bone demineralization and abnormalities in serum Ca, P
and Ca regulatory agents. From these studies, an improved understanding of
mechanisms involved in bone mineralization in high risk infants will be
obtained and provide a means of assessing Ca regulatory mechanisms in such
infants.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
DUNS Number
041064767
UEI
DZ4YCZ3QSPR5
Project Start Date
01-January-1985
Project End Date
31-December-1987
Budget Start Date
01-January-1985
Budget End Date
31-December-1985
Project Funding Information for 1985
Total Funding
$70,670
Direct Costs
$50,113
Indirect Costs
$20,557
Year
Funding IC
FY Total Cost by IC
1985
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$70,670
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01HD018505-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01HD018505-01A1
Patents
No Patents information available for 1R01HD018505-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01HD018505-01A1
Clinical Studies
No Clinical Studies information available for 1R01HD018505-01A1
News and More
Related News Releases
No news release information available for 1R01HD018505-01A1
History
No Historical information available for 1R01HD018505-01A1
Similar Projects
No Similar Projects information available for 1R01HD018505-01A1